Ami Bhatt and Jagat Narula discuss the global impact of rheumatic heart disease, its challenges, and ongoing efforts for ...
As the researchers saw no link between elevated Lp (a) and VTE risk in men or postmenopausal women not on hormone therapy, the findings indicate that sex hormones may play a greater role than ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Three countries with different systems achieved similar levels of control, indicating that efforts to lessen CV risk should ...
The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...
The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.
Twenty years of data from New England highlight geographical challenges, which some say may merit a rethink of STEMI care.
Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.
Strait Access Technologies e-mail: info@sat.za.com, a medical technology company developing next-generation cardiovascular ...
Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...
With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.
More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results